Weight Loss Drug Belviq Pulled From Shelves After FDA Warns of Cancer Risk

A study designed to rule out heart-risk found a slightly higher incidence of cancer among those who took the drug for one year.

Published Feb 14, 2020

NOW
PLAYING
A Promising New Study Suggests Women with an Aggressive Form of Breast Cancer Could Benefit from Immunotherapy
NOW
PLAYING
Popular Weight-Loss Drug Belviq May Increase Cancer Risk, FDA Warns
NOW
PLAYING
It's Not Just Zantac -- More Heartburn Drugs Pulled From Shelves Due to Potential Cancer Risk
NOW
PLAYING
New Information About Who Benefits from Immunotherapy in Lung Cancer
NOW
PLAYING
Zantac Caused My Breast Cancer, Florida Woman Asserts in New Lawsuit
NOW
PLAYING
Hopeful News for Breast Cancer: A New Drug Combination to Extend Survival Time
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.